Case series reports culture-confirmed corynebacterium infections in cancer patients undergoing radiation therapy, highlighting clinical implications.
Corynebacterium species are increasingly recognized as opportunistic pathogens in immunocompromised hosts. We report three cases of culture-confirmed Corynebacterium infections in cancer patients undergoing radiation therapy at a tertiary care centre. Two patients developed Corynebacterium striatum skin and soft tissue infections and one had Corynebacterium matruchotii vaginal infection. All cases presented with foul-smelling discharge and delayed wound healing in previously irradiated tissues. Identification was performed using MALDI-TOF MS (Bruker Biotyper®) and standard microbiological methods. Direct Gram stain of all specimens revealed gram-positive, pleomorphic rod-shaped bacilli. Antimicrobial susceptibility testing confirmed susceptibility to linezolid in all isolates, and culture-guided therapy with linezolid resulted in rapid clinical improvement. These cases highlight the importance of recognizing Corynebacterium species as true pathogens rather than contaminants in immunocompromised cancer patients.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: